logo
Plus   Neg
Share
Email
Comment

AstraZeneca Pulls Back Off Best Levels But Remains Positive

After showing a strong upward move early in the session, shares of AstraZeneca (AZN) have given back some ground but remain positive in afternoon trading on Friday. AstraZeneca is currently up by 1.9 percent after reaching a six-month intraday high.

The early rally by AstraZeneca came after JPMorgan Chase upgraded its rating on the biopharmaceutical company to Overweight from Neutral.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Amid a government shutdown, the Senate voted Monday to move forward on a short-term spending bill to re-open the government. The Senate voted 81 to 18 in favor of limiting debate on the bill, which would fund the government through February 8th. Opera, a web browser for Windows, macOS, and Linux operating systems, has added cryptocurrency mining protection to its mobile browsers. It is part of the browser's ad blocker function. In its desktop-based versions, Opera had introduced cryptocurrency miner protection in early January. French drug giant Sanofi SA Monday announced an agreement to buy US-based hemophilia drugmaker Bioverativ Inc. (BIVV) for around $11.6 billion. The deal expands Sanofi's presence in specialty care and strengthens leadership in rare diseases. Sanofi shares were losing around 4 percent in the early morning trading in Paris.
comments powered by Disqus
Follow RTT